Clin2
NCT07163078Possibly a fitNot yet recruiting

Nutrition supplement for cystic fibrosis

Cystic Fibrosis (CF)

Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.

This study tests whether a special nutrition supplement can improve health in adults with cystic fibrosis and pancreatic insufficiency who are already on a modulator therapy. The goal is to see if the supplement helps with digestion and overall well-being.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You have a diagnosis of cystic fibrosis
  • You have exocrine pancreatic insufficiency (your pancreas doesn't make enough digestive enzymes)
  • You are 18 years old or older
  • You are currently taking a CFTR modulator (a medication like Trikafta that targets the underlying cause of CF)
  • Your liver enzyme blood tests are within normal limits
  • You are not currently taking certain supplements like high-dose vitamin D, vitamin E, or copper, and you don't have a history of liver problems

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07223255Recruiting
Mediterranean diet study for children with cystic fibrosis

This study tests whether a Mediterranean-style diet can improve gastrointestinal health in children with cystic fibrosis. It requires families to follow the diet for 6 months and attend regular clinic visits.

Lebanon, New Hampshire
NCT07148739Recruiting· Phase 4
Ensuring Best Access to CF Treatment

This study tests whether people with cystic fibrosis who are already on a triple combination CFTR modulator can stay on their treatment without interruptions or problems. It aims to make sure everyone gets the best, most consistent treatment for their CF.

Birmingham, Alabama
NCT07450547Recruiting· Phase 2
A trial of a new medicine for cystic fibrosis and pancreatic problems

This trial tests a new medicine (ANG003) for people with cystic fibrosis who have severe pancreatic problems. It looks at how safe and effective the medicine is, and whether it helps with digestion.

Long Beach, California
NCT06163482Recruiting
Meal Hormone Study in Cystic Fibrosis

This study looks at how the body processes a mixed meal in people with cystic fibrosis who are on CFTR modulator therapy. It may help researchers understand how these medications change hormone and blood sugar responses.

Cincinnati, Ohio
NCT04580368Recruiting
Personalized drug testing for cystic fibrosis using small trials

This trial tests how well cystic fibrosis (CF) medicine works for you using an “n-of-1” approach, meaning you try treatments in a structured, repeated way to see what helps you most. It may help your care team choose the best option for your specific CF genetics and health status.

Cincinnati, Ohio
NCT05766774Recruiting
Diet study for adults with cystic fibrosis and high sugar intake

This trial studies whether changing eating habits—especially added sugar intake—affects health in adults with cystic fibrosis. It may help by testing a diet approach aimed at better outcomes related to metabolism and overall health.

Atlanta, Georgia

Hear when a new Cystic Fibrosis (CF) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.